Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda
- Sponsor
- University of California, San Francisco
- Study ID
- NCT04030520
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 15 Years - 24 Years
- Healthy Volunteers
- Accepted
Interventions
- POPPi — BEHAVIORALbehavioral intervention with offer of HIV self test
- Comparison — BEHAVIORALstandard of care
Study Details
The main aim is to develop and assess an intervention to enhance initiation and adherence to PrEP among HIV negative young women of high risk (YWHR). The specific aims are (1) To conduct formative research to enhance our understanding of the dynamics of the social and sexual networks, and context of young HIV-uninfected women (aged 15-24) engaged in high risk sexual behavior in Kampala, Uganda (2) Document barriers and opportunities for PrEP uptake and adherence as well as repeat HIV testing by self test; (3) To develop and test a socially and culturally acceptable and feasible prevention intervention on uptake and adherence to PrEP and HIV self-testing for young women at high risk for HIV.
Key Dates
- Start date
- Jul 8, 2019
- Status verified
- Jul 2025
- Primary completion
- Oct 31, 2020
- Completion
- Oct 31, 2021
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: interventionparticipants will receive a behavioral intervention including counseling and offer of HIV oral fluid self test and PrEP
- Active Comparator: comparisonparticipants will be not be offered HIV oral fluid self test but receive counseling, condoms and offered PrEP
Primary Outcome Measure
Initiation of PrEP [ Time Frame: 6 months ]
Related Studies
- Project I Test: Implementing HIV Testing in Opioid Treatment ProgramsRecruiting · Columbia University · New York, New York
- An mHealth Intervention to Improve Outcomes for Women With HIV/AIDSRecruiting · University of Miami · Miami, Florida
- Observational Pharmaco-Epidemiology Research & AnalysisRecruiting · Epividian · Durham, North Carolina
- SCOPE Analytic Treatment Interruption ProtocolRecruiting · University of California, San Francisco · San Francisco, California